213 related articles for article (PubMed ID: 11128675)
1. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
[TBL] [Abstract][Full Text] [Related]
2. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.
Margaglione M; D'Andrea G; d'Addedda M; Giuliani N; Cappucci G; Iannaccone L; Vecchione G; Grandone E; Brancaccio V; Di Minno G
Thromb Haemost; 1998 May; 79(5):907-11. PubMed ID: 9609218
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes.
Alhenc-Gelas M; Arnaud E; Nicaud V; Aubry ML; Fiessinger JN; Aiach M; Emmerich J
Thromb Haemost; 1999 Apr; 81(4):506-10. PubMed ID: 10235429
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR.
Hessner MJ; Luhm RA; Pearson SL; Endean DJ; Friedman KD; Montgomery RR
Thromb Haemost; 1999 May; 81(5):733-8. PubMed ID: 10365746
[TBL] [Abstract][Full Text] [Related]
5. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels.
Cattaneo M; Chantarangkul V; Taioli E; Santos JH; Tagliabue L
Thromb Res; 1999 Jan; 93(1):1-8. PubMed ID: 10065893
[TBL] [Abstract][Full Text] [Related]
6. Factor V Leiden mutation in patients with Behçet's disease.
Oner AF; Gürgey A; Gürler A; Mesci L
J Rheumatol; 1998 Mar; 25(3):496-8. PubMed ID: 9517770
[TBL] [Abstract][Full Text] [Related]
7. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase in extreme old age.
Rees DC; Liu YT; Cox MJ; Elliott P; Wainscoat JS
Thromb Haemost; 1997 Nov; 78(5):1357-9. PubMed ID: 9408019
[TBL] [Abstract][Full Text] [Related]
8. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis.
Kluijtmans LA; den Heijer M; Reitsma PH; Heil SG; Blom HJ; Rosendaal FR
Thromb Haemost; 1998 Feb; 79(2):254-8. PubMed ID: 9493571
[TBL] [Abstract][Full Text] [Related]
9. Association of factor V Leiden with Behçet's disease.
Mammo L; Al-Dalaan A; Bahabri SS; Saour JN
J Rheumatol; 1997 Nov; 24(11):2196-8. PubMed ID: 9375883
[TBL] [Abstract][Full Text] [Related]
10. No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.
Rintelen C; Mannhalter C; Lechner K; Eichinger S; Kyrle PA; Papagiannopoulos M; Schneider B; Pabinger I
Blood Coagul Fibrinolysis; 1999 Mar; 10(2):101-5. PubMed ID: 10192659
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence of Factor V Leiden and the G20210A mutation of the prothrombin gene in a random group of patients with thrombotic episodes].
Alvarez A; Barroso A; Robledo M; Arranz E; Outeiriño J; Benítez J
Sangre (Barc); 1999 Feb; 44(1):7-12. PubMed ID: 10323090
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors.
Antoniadi T; Hatzis T; Kroupis C; Economou-Petersen E; Petersen MB
Am J Hematol; 1999 Aug; 61(4):265-7. PubMed ID: 10440914
[TBL] [Abstract][Full Text] [Related]
13. The mutation Ala677-->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis.
Arruda VR; von Zuben PM; Chiaparini LC; Annichino-Bizzacchi JM; Costa FF
Thromb Haemost; 1997 May; 77(5):818-21. PubMed ID: 9184384
[TBL] [Abstract][Full Text] [Related]
14. Placental genotyping of the factor V Leiden, prothrombin 20210A and the methylenetetrahydrofolate reductase (MTHFR) C677T alleles in IUGR pregnancies.
Wisotzkey JD; Bayliss P; Rutherford E; Bell T
Thromb Haemost; 1999 May; 81(5):844-5. PubMed ID: 10365762
[No Abstract] [Full Text] [Related]
15. Multiplex ASA PCR for a simultaneous determination of factor V Leiden gene, G-->A 20210 prothrombin gene and C-->T 677 MTHFR gene mutations.
Hézard N; Cornillet-Lefebvre P; Gillot L; Potron G; Nguyen P
Thromb Haemost; 1998 May; 79(5):1054-5. PubMed ID: 9609246
[No Abstract] [Full Text] [Related]
16. A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease.
Franco RF; Morelli V; Lourenço D; Maffei FH; Tavella MH; Piccinato CE; Thomazini IA; Zago MA
Br J Haematol; 1999 May; 105(2):556-9. PubMed ID: 10233437
[TBL] [Abstract][Full Text] [Related]
17. Factor V Leiden (G1691A), the prothrombin 3'-untranslated region variant (G20210A) and thermolabile methylenetetrahydrofolate reductase (C677T): a single genetic test genotypes all three loci--determination of frequencies in the S. Wales population of the UK.
Bowen DJ; Bowley S; John M; Collins PW
Thromb Haemost; 1998 May; 79(5):949-54. PubMed ID: 9609227
[TBL] [Abstract][Full Text] [Related]
18. Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations.
Grandone E; Margaglione M; Colaizzo D; D'Andrea G; Cappucci G; Brancaccio V; Di Minno G
Am J Obstet Gynecol; 1998 Nov; 179(5):1324-8. PubMed ID: 9822524
[TBL] [Abstract][Full Text] [Related]
19. Frequency of factor V (FV) Leiden and C677T methylenetetrahydrofolate reductase (MTHFR) mutations in Colombians.
Camacho Vanegas O; Giusti B; Restrepo Fernandez CM; Abbate R; Pepe G
Thromb Haemost; 1998 Apr; 79(4):883-4. PubMed ID: 9569213
[No Abstract] [Full Text] [Related]
20. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation.
Lindmarker P; Schulman S; Sten-Linder M; Wiman B; Egberg N; Johnsson H
Thromb Haemost; 1999 May; 81(5):684-9. PubMed ID: 10365737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
